{"id":"https://openalex.org/W4385667331","doi":"https://doi.org/10.1097/01.hs9.0000970780.55147.2c","title":"P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY","display_name":"P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY","alternate_titles":[],"publication_year":2023,"publication_date":"2023-08-01","ids":{"openalex":"https://openalex.org/W4385667331","doi":"https://doi.org/10.1097/01.hs9.0000970780.55147.2c","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10431519"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000970780.55147.2c","doi":"https://doi.org/10.1097/01.hs9.0000970780.55147.2c","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000970780.55147.2c","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4385667331"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1097/01.hs9.0000970780.55147.2c","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013808699","display_name":"Jakob Nordberg N\u00f8rgaard","orcid":"https://orcid.org/0000-0002-8762-0530","observed_orcids":["https://orcid.org/0000-0002-8762-0530"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Jakob Nordberg N\u00f8rgaard","raw_affiliation_strings":["Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084748102","display_name":"Kari Lenita Falck Moore","orcid":"https://orcid.org/0000-0002-2190-2762","observed_orcids":["https://orcid.org/0000-0002-2190-2762"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Kari Lenita Falck Moore","raw_affiliation_strings":["Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071862673","display_name":"Tobias Schmidt Sl\u00f8rdahl","orcid":"https://orcid.org/0000-0001-7488-4863","observed_orcids":["https://orcid.org/0000-0001-7488-4863"]},"institutions":[{"id":"https://openalex.org/I4210104358","display_name":"St Olav's University Hospital","ror":"https://ror.org/01a4hbq44","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210104358"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Tobias Sl\u00f8rdahl","raw_affiliation_strings":["Department of Hematology, St. Olavs Hospital, Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, St. Olavs Hospital, Trondheim, Norway","institution_ids":["https://openalex.org/I4210104358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052877657","display_name":"Anders Vik","orcid":"https://orcid.org/0000-0002-7864-3271","observed_orcids":["https://orcid.org/0000-0002-7864-3271"]},"institutions":[{"id":"https://openalex.org/I1298853749","display_name":"University Hospital of North Norway","ror":"https://ror.org/030v5kp38","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1298853749","https://openalex.org/I63903255"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Anders Vik","raw_affiliation_strings":["Department of Hematology, University Hospital of North Norway, Troms\u00f8, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University Hospital of North Norway, Troms\u00f8, Norway","institution_ids":["https://openalex.org/I1298853749"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053862074","display_name":"Tor Henrik Anderson Tvedt","orcid":"https://orcid.org/0000-0003-1642-9648","observed_orcids":["https://orcid.org/0000-0003-1642-9648"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Tor Henrik Anderson Tvedt","raw_affiliation_strings":["Department of Hematology, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078740906","display_name":"Fredrik Hellem Schjesvold","orcid":"https://orcid.org/0000-0003-1096-0569","observed_orcids":["https://orcid.org/0000-0003-1096-0569"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Fredrik Schjesvold","raw_affiliation_strings":["Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"S3","first_page":"e551472c","last_page":"e551472c"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.800000011920929},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.8949999809265137},{"id":"https://openalex.org/keywords/vrd-regimen","display_name":"VRd regimen","score":0.7929999828338623},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.8100000023841858},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9150000214576721},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.7749999761581421},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.4970000088214874},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9129999876022339},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.984000027179718},{"id":"https://openalex.org/keywords/newly-diagnosed-multiple-myeloma","display_name":"newly diagnosed multiple myeloma","score":0.7440000176429749},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.9070000052452087},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.9599999785423279},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.3479999899864197},{"id":"https://openalex.org/keywords/norway","display_name":"Norway","score":0.6690000295639038},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.38600000739097595}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8102885484695435},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7290648221969604},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7240936160087585},{"id":"https://openalex.org/C2779050716","wikidata":"https://www.wikidata.org/wiki/Q4826373","display_name":"Autologous stem-cell transplantation","level":3,"score":0.719386100769043},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.6797419786453247},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5860817432403564},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5753275156021118},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5704600811004639},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5168555378913879},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.4424351155757904},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2988215684890747},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000970780.55147.2c","doi":"https://doi.org/10.1097/01.hs9.0000970780.55147.2c","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000970780.55147.2c","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10431519","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10431519","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10431519/pdf/hs9-7-e551472c.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:1a193b79f00444d1bbaec692ad599499","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1a193b79f00444d1bbaec692ad599499","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 7, p e551472c (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000970780.55147.2c","doi":"https://doi.org/10.1097/01.hs9.0000970780.55147.2c","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000970780.55147.2c","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385667331.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4394613125","https://openalex.org/W2981207131","https://openalex.org/W3213320033","https://openalex.org/W4220738064","https://openalex.org/W2949680186","https://openalex.org/W4385654761","https://openalex.org/W2801920373","https://openalex.org/W2911919635","https://openalex.org/W2508727296","https://openalex.org/W2980241495"],"abstract_inverted_index":{"Topic:":[0],"14.":[1],"Myeloma":[2],"and":[3,35,89,112,137,150,202,206,219,255,284,404,533,597,607],"other":[4],"monoclonal":[5],"gammopathies":[6],"-":[7],"Clinical":[8],"Background:":[9],"Induction":[10],"therapy":[11,64,116,232,292,412,589],"followed":[12],"by":[13],"autologous":[14],"stem":[15],"cell":[16],"transplantation":[17],"(ASCT)":[18],"is":[19],"standard":[20],"of":[21,44,86,103,230,301,349,366,369,393,397,526],"care":[22],"for":[23,65,164,268,418],"young,":[24],"fit":[25],"patients":[26,158,261,280,302,351,370,394,398,499,570,584],"with":[27,295,299,327,329,515,554,586],"newly":[28,165],"diagnosed":[29,166],"multiple":[30,167,269],"myeloma.":[31],"Both":[32],"bortezomib-lenalidomide-dexamethasone":[33],"(VRd)":[34],"bortezomib-cyclophosphamide-dexamethasone":[36],"(VCd)":[37],"are":[38,46,54],"widely":[39],"in":[40,76,159,169,189,197,221,253,271,273,303,313,331,339,360,378,399,424,442,465,475,529,536,546,575],"use,":[41],"although":[42],"none":[43],"them":[45],"EMA":[47],"approved.":[48],"Prospective":[49],"studies":[50],"comparing":[51],"these":[52],"regimens":[53,110],"lacking.":[55],"In":[56,344,505,563],"Norway,":[57],"most":[58],"regions":[59],"used":[60],"VCd":[61,111,203,220,282,315,341,346,410,419,444,531,538],"as":[62,114,226,265,355,373,600,602],"induction":[63,115,231,283,291,588],"about":[66],"a":[67,495,523],"decade.":[68],"However,":[69],"the":[70,84,93,104,109,170,195,215,274,304,314,332,340,345,361,400,425,443,466,476,485,508,530,537,540],"Oslo":[71],"region":[72],"shifted":[73],"towards":[74],"VRd":[75,113,201,218,286,296,305,333,362,401,426,467,477,486,516,555,587],"recent":[77],"years,":[78],"based":[79],"on":[80],"data":[81,121,184],"showing":[82],"that":[83,126,583],"combination":[85],"immunomodulatory":[87],"drugs":[88],"proteasome":[90],"inhibitors":[91],"have":[92],"highest":[94],"response":[95,135,198,236,242,322,592],"rates":[96,136,199,289,323,593],"(Moreau,":[97],"Blood":[98],"2016).":[99],"Aims:":[100],"The":[101,191,211,376,469,549],"aim":[102],"study":[105,275,567],"was":[106,194,214,380,472,511,543,552],"to":[107,129,133,140,175,431,579,610],"compare":[108],"before":[117,204,309,595],"ASCT":[118,163,205,264,391,437,574,596],"using":[119],"population-based":[120],"from":[122,185,577],"Norway.":[123,190],"We":[124,155,223,258],"hypothesized":[125],"VRd,":[127,328,421],"compared":[128,609],"VCd,":[130,298],"would":[131],"lead":[132],"higher":[134,294,326,358,474,514,553,591],"less":[138],"need":[139],"change":[141,229],"therapy,":[142,492],"which":[143],"again":[144],"could":[145],"improve":[146],"progression-free":[147],"survival":[148,152],"(PFS)":[149],"overall":[151],"(OS).":[153],"Methods:":[154],"included":[156],"all":[157,186,462,569],"Norway":[160,272,576],"who":[161,262,408,500,571],"received":[162,263,281,490,502,572],"myeloma":[168,270,617],"period":[171],"January":[172],"1st":[173],"2008":[174,578],"December":[176],"31th":[177],"2020.":[178],"Using":[179],"electronic":[180],"journals,":[181],"we":[182,493,581],"collected":[183],"transplant":[187],"centers":[188],"primary":[192],"endpoint":[193,213],"difference":[196,216,377],"between":[200,217],"3":[207,245,388],"months":[208,246,319,389,528,535],"after":[209,247,290,320,390,436,598],"ASCT.":[210],"co-primary":[212],"failure.":[222],"defined":[224],"failure":[225,374,379],"either":[227,547],"1)":[228],"or":[233,456],"2)":[234],"poor":[235],"(less":[237],"than":[238,359,441],"very":[239],"good":[240],"partial":[241],"(VGPR)":[243],"at":[244],"ASCT).":[248],"Secondary":[249],"endpoints":[250],"were":[251,293,324,353,371,428,461],"differences":[252],"PFS":[254,471,510,606],"OS.":[256],"Results:":[257],"identified":[259],"1354":[260],"first-line":[266,434,573],"treatment":[267,435,447,452],"period.":[276],"Of":[277],"these,":[278],"682":[279],"332":[285],"induction.":[287],"Response":[288],"vs":[297,311,337,395,416,420,439,449,454,459,480,518,557],"73%":[300],"group":[306,316,334,342,427,478,487,532],"achieving":[307,335],"\u2265VGPR":[308],"ASCT,":[310,321,599],"47%":[312],"(p<0.001).":[317,343,375],"Three":[318],"also":[325],"89%":[330],"\u2265VGPR,":[336],"75%":[338],"group,":[347,363,402,539],"193":[348],"646":[350],"(30%)":[352],"classified":[354,372],"failure,":[356],"significantly":[357,473,513,603],"where":[364],"51":[365],"330":[367],"(15%)":[368],"mainly":[381],"because":[382,406],"VCd-patients":[383],"more":[384,413,429,463,488],"often":[385,489],"achieved":[386],"<VGPR":[387],"(22%":[392],"10%":[396],"p<0.001),":[403],"not":[405,544],"those":[407],"started":[409],"changed":[411],"frequently":[414],"(7%":[415],"5%":[417],"p=0.250)":[422],"Patients":[423],"likely":[430],"receive":[432],"further":[433],"(63%":[438],"14%)":[440],"group;":[445],"consolidation":[446],"(23%":[448],"1%),":[450],"maintenance":[451,491,503],"(26%":[453],"10%)":[455],"both":[457,594],"(14%":[458],"3%)":[460],"frequent":[464],"group.":[468,548],"3-year":[470,509,550,605],"(67%":[479],"40%,":[481],"p":[482,520,559],"<0.001).":[483,521],"As":[484],"did":[494],"separate":[496],"analysis":[497],"excluding":[498],"had":[501,590],"therapy.":[504],"this":[506,564],"analysis,":[507],"still":[512],"(60%":[517],"36%,":[519],"After":[522],"median":[524,541],"follow-up":[525],"89":[527],"39":[534],"OS":[542,551],"reached":[545],"(92%":[556],"85%,":[558],"=":[560],"0.02)":[561],"Summary/Conclusion:":[562],"population-based,":[565],"retrospective":[566],"including":[568],"2020,":[580],"found":[582],"treated":[585],"well":[601],"better":[604],"OS,":[608],"VCd.Keywords:":[611],"Real":[612],"world":[613],"data,":[614],"Induction,":[615],"Multiple":[616]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4385667331","counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2023-08-09T00:00:00"}
